Expanded case series includes advanced thymic carcinoma, small cell lung cancer, pancreatic cancer, end-stage liver cirrhosis, and end-stage renal disease According to patient accounts, multiple ...
Case involving senior dosimetrist at a premier cancer hospital in the Northeast suggests potential relevance of Phyto-N in one of oncology’s most ...
Cachexia is a condition which denotes the excessive loss of weight. It occurs because of the depletion of adipose tissue and muscle mass in people who are not trying to lose weight. It is also known ...
A majority of people with advanced cancers endure cachexia, a muscle-, fat-, and organ-wasting condition that is currently ...
Curanex Pharmaceuticals Inc. CURX on Wednesday highlighted five additional patient cases that management believes further ...
It has been known for many years that advanced cancer is associated with a wasting syndrome that speeds the demise of patients. About one-quarter to a third of patients with advanced cancer develop ...
Cachexia in older SCLC patients leads to inferior survival rates and increased treatment complications, such as dose reductions and incomplete chemotherapy courses. Patients with cachexia had ...
Halting the advance of a muscle wasting condition called cachexia, could improve quality of life for cancer sufferers. For many years, oncologists and researchers thought the dramatic weight-loss of ...
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results